Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Histogen Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 13 | 9 | −4 |
| Shares | 151.6K | 18.5K | −133.1K (−87.8%) |
| Value | $107.8K | $9.53K | −$98.3K (−91.2%) |
New holders (2)
Institutions that held Histogen Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 89 | $46 | 0.00% |
| Highlander Capital Management, LLC | 17 | $0 | 0.00% |
Sold out (6)
Institutions that held Histogen Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Vanguard Group Inc | 60,166 | $42.8K |
| BlackRock Inc. | 34,910 | $24.8K |
| Two Sigma Securities, LLC | 10,491 | $7.46K |
| Geode Capital Management, LLC | 10,249 | $7.30K |
| Tower Research Capital LLC (TRC) | 9,270 | $6.59K |
| Northwestern Mutual Wealth Management Co | 1 | $1 |